Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4780-4788

  Hietala, Sofia Friberg ^a   Mårtensson, Andreas ^b,c   Ngasala, Billy ^d   Dahlström, Sabina ^b   Lindegårdh, Niklas ^e,f   Annerberg, Anna ^e   Premji, Zul ^d   Färnert, Anna ^b   Gil, Pedro ^b,g   Björkman, Anders ^b   Ashton, Michael ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^e MAHIDOL UNIVERSITY   (Thailand)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ARTEMETHER PLUS BENFLUMETOL; CLOXACILLIN; DIHYDROARTEMISININ; IRON;

ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG FATALITY; FEMALE; HOST PARASITE INTERACTION; HUMAN; IRON THERAPY; MALARIA FALCIPARUM; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; TANZANIA; UNSPECIFIED SIDE EFFECT;

ANTIMALARIALS; ARTEMISININS; BODY TEMPERATURE; CHILD; CHILD, PRESCHOOL; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; TANZANIA; TREATMENT OUTCOME;

EID: 78049272272     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00252-10     Document Type: Article

References (38)

1. Alin, M. H., A. Bjorkman, and M. Ashton. 1990. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 84:635-637.
2. Annerberg, A., T. Singtoroj, P. Tipmanee, N. J. White, N. P. Day, and N. Lindegardh. 2005. High throughput assay for the determination of lumefantrine in plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 822: 330-333.
3. Ashley, E. A., K. Stepniewska, N. Lindegardh, A. Annerberg, A. Kham, A. Brockman, P. Singhasivanon, N. J. White, and F. Nosten. 2007. How much fat is necessary to optimize lumefantrine oral bioavailability? Trop. Med. Int. Health 12:195-200.
4. Beal, S. L., and L. B. Sheiner. 1982. Estimating population kinetics. Crit. Rev. Biomed. Eng. 8:195-222.
5. Checchi, F., P. Piola, C. Fogg, F. Bajunirwe, S. Biraro, F. Grandesso, E. Ruzagira, J. Babigumira, I. Kigozi, J. Kiguli, J. Kyomuhendo, L. Ferradini, W. R. Taylor, and J. P. Guthmann. 2006. Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malar. J. 5:59.
6. Dondorp, A. M., V. Desakorn, W. Pongtavornpinyo, D. Sahassananda, K. Silamut, K. Chotivanich, P. N. Newton, P. Pitisuttithum, A. M. Smithyman, N. J. White, and N. P. Day. 2005. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2:e204.
7. Ezzet, F., R. Mull, and J. Karbwang. 1998. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br. J. Clin. Pharmacol. 46:553-561.
8. Ezzet, F., M. van Vugt, F. Nosten, S. Looareesuwan, and N. J. White. 2000. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob. Agents Chemother. 44:697-704.
9. Falade, C., M. Makanga, Z. Premji, C. E. Ortmann, M. Stockmeyer, and P. I. de Palacios. 2005. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 99:459-467.
10. Farnert, A., M. Lebbad, L. Faraja, and I. Rooth. 2008. Extensive dynamics of Plasmodium falciparum densities, stages and genotyping profiles. Malar. J. 7:241.
11. Farnert, A., G. Snounou, I. Rooth, and A. Bjorkman. 1997. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 56:538-547.
12. Gordi, T., R. Xie, and W. J. Jusko. 2005. Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin. Br. J. Clin. Pharmacol. 60:594-604.
13. Gravenor, M. B., A. L. Lloyd, P. G. Kremsner, M. A. Missinou, M. English, K. Marsh, and D. Kwiatkowski. 2002. A model for estimating total parasite load in falciparum malaria patients. J. Theor. Biol. 217:137-148.
14. Hanpithakpong, W., B. Kamanikom, A. M. Dondorp, P. Singhasivanon, N. J. White, N. P. Day, and N. Lindegardh. 2008. A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 876:61-68.
15. Hatz, C., S. Abdulla, R. Mull, D. Schellenberg, I. Gathmann, P. Kibatala, H. P. Beck, M. Tanner, and C. Royce. 1998. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop. Med. Int. Health 3:498-504.
16. Holford, N. 2005. A degenerative predictive check, abstr. 738, p. 14. 14th Annu. Meet. Pop. Appr. Group Eur., Pamplona, Spain.
17. Hoshen, M. B., R. Heinrich, W. D. Stein, and H. Ginsburg. 2000. Mathematical modelling of the within-host dynamics of Plasmodium falciparum. Parasitology 121:227-235.
18. Jafari, S., J. Le Bras, O. Bouchaud, and R. Durand. 2004. Plasmodium falciparum clonal population dynamics during malaria treatment. J. Infect. Dis. 189:195-203.
19. Jafari-Guemouri, S., C. Boudin, N. Fievet, P. Ndiaye, and P. Deloron. 2006. Plasmodium falciparum genotype population dynamics in asymptomatic children from Senegal. Microbes Infect. 8:1663-1670.
20. Jonsson, E. N., and M. O. Karlsson. 1999. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput. Methods Programs Biomed. 58:51-64.
21. Kabanywanyi, A. M., A. Mwita, D. Sumari, R. Mandike, K. Mugittu, and S. Abdulla. 2007. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar. J. 6:146.
22. Lefevre, G., P. Carpenter, C. Souppart, H. Schmidli, J. M. Martin, A. Lane, C. Ward, and D. Amakye. 2002. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. J. Clin. Pharmacol. 42: 1147-1158.
23. Lindbom, L., P. Pihlgren, and E. N. Jonsson. 2005. PsN-Toolkit - a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput. Methods Programs Biomed. 79:241-257.
24. Martensson, A., B. Ngasala, J. Ursing, M. Isabel Veiga, L. Wiklund, C. Membi, S. M. Montgomery, Z. Premji, A. Farnert, and A. Bjorkman. 2007. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. J. Infect. Dis. 195:597-601.
25. Mårtensson, A., J. Stromberg, C. Sisowath, M. I. Msellem, J. P. Gil, S. M. Montgomery, P. Olliaro, A. S. Ali, and A. Bjorkman. 2005. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin. Infect. Dis. 41:1079-1086.
26. Mordi, M. N., S. M. Mansor, V. Navaratnam, and W. H. Wernsdorfer. 1997. Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers. Br. J. Clin. Pharmacol. 43:363-365.
27. Na Bangchang, K., J. Karbwang, C. G. Thomas, A. Thanavibul, K. Sukontason, S. A. Ward, and G. Edwards. 1994. Pharmacokinetics of artemether after oral administration to healthy Thai patients with acute, uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. 37:249-253.
28. Piola, P., C. Fogg, F. Bajunirwe, S. Biraro, F. Grandesso, E. Ruzagira, J. Babigumira, I. Kigozi, J. Kiguli, J. Kyomuhendo, L. Ferradini, W. Taylor, F. Checchi, and J. P. Guthmann. 2005. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 365:1467-1473.
29. Simpson, J. A., L. Aarons, W. E. Collins, G. M. Jeffery, and N. J. White. 2002. Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology 124:247-263.
30. Svensson, U. S., H. Alin, M. O. Karlsson, Y. Bergqvist, and M. Ashton. 2002. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. Eur. J. Clin. Pharmacol. 58:339-351.
31. Teja-Isavadharm, P., F. Nosten, D. E. Kyle, C. Luxemburger, F. Ter Kuile, J. O. Peggins, T. G. Brewer, and N. J. White. 1996. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br. J. Clin. Pharmacol. 42:599-604.
32. Udomsangpetch, R., B. Pipitaporn, K. Silamut, R. Pinches, S. Kyes, S. Looareesuwan, C. Newbold, and N. J. White. 2002. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 99:11825-11829.
33. van Agtmael, M. A., S. Cheng-Qi, J. X. Qing, R. Mull, and C. J. van Boxtel. 1999. Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria. Int. J. Antimicrob. Agents 12:151-158.
34. van Agtmael, M. A., V. Gupta, C. A. van der Graaf, and C. J. van Boxtel. 1999. The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects. Clin. Pharmacol. Ther. 66:408-414.
35. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
36. White, N. J., D. Chapman, and G. Watt. 1992. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 86:590-597.
37. White, N. J., M. van Vugt, and F. Ezzet. 1999. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin. Pharmacokinet. 37:105-125.
38. WHO. 2006. WHO guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.